Home / Caspofungin / Switzerland
CH ATC J02AX04 · updated 2 Nov 2026
Caspofungin shortage in Switzerland
Is there a Caspofungin shortage in Switzerland?
Yes. As of 2 Nov 2026, 4 Caspofungin products are reported short in Switzerland, the first since 15 May 2026. The company estimate for the return is 29 Jan 2027. Main reason: not stated.
Also short in United States, Canada, Italy, Sweden. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | CASPOFUNGIN Sandoz eco Trockensub 50 mg Vial | Sandoz Pharmaceuticals AG | 15 May 2026 | not given | Not stated |
| CH | CASPOFUNGIN Mepha Trockensub 70 mg Durchstf | Mepha Pharma AG | 30 Jun 2026 | not given | Not stated |
| CH | CASPOFUNGIN Viatris Trockensub 50 mg Durchstf | Viatris Pharma GmbH | 30 Sep 2026 | 29 Jan 2027 | Not stated |
| CH | CASPOFUNGIN Mepha Trockensub 50 mg Durchstf anticipated | Mepha Pharma AG | 31 Jan 2027 | not given | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).